ArticleJournal of Alzheimer's disease reports2024

An Open-Label, Pilot Study of Daratumumab SC in Mild to Moderate Alzheimer's Disease.

Marc L Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.